Literature DB >> 35560177

Clinical significance of differential serum-signatures for early prediction of severe dengue among Eastern Indian patients.

Saikat Mukherjee1, Bibhuti Saha2, Anusri Tripathi1.   

Abstract

Dengue infection can result in simple dengue fever or life-threatening severe dengue. Early identification of severe patients is needed for proper disease management. Dengue infection was screened among 168 symptomatic patients by qRT-PCR, anti-dengue IgM, and IgG ELISA. Dengue patients were categorized according to WHO classification. Viral load and dengue serotypes were determined by qRT-PCR. Levels of acute-phase-proteins (SAP, SAA2; CRP and ApoA1), endothelial (Ang2, VEGF), coagulation (fibrinogen) markers were determined by sandwich ELISA/immunoturbidimetry/western-blotting. Hepatic (ALT, AST, ALP) and other blood biochemical parameters were studied by autoanalyzer and haematology cell counter. Statistical analysis and protein-protein-interaction network were performed by GraphPad-Prism and STRINGS database, respectively. Among 87 dengue patients, significantly higher levels of Ang2, VEGF, CRP, SAA2, ApoA1, AST, ALT, and AST/ALT ratio and low level of fibrinogen were detected in severe-dengue cases compared to dengue without warning-signs, with seven of them severely altered during febrile-phase. Higher fold-change of Ang2 and VEGF as well as decreased fibrinogen were observed among patients with haemorrhagic-manifestation, clinical-fluid accumulation and thrombocytopenia. Functional network analysis predicted Ang2, VEGF, and CRP to be functionally and physically connected and SAA2 and ApoA1 to be functioning together. Correlation analyses also validated this connectivity by a strong positive correlation between Ang2, VEGF, and CRP. PCA analysis followed by hierarchical clustering heatmap analysis segregated severe-dengue patients from the rest, with VEGF, Ang2, ApoA1, AST, and ALT clearly distinguishing the severe-dengue group. Thus, serum levels of VEGF, Ang2, ApoA1, AST, and ALT might act as potential biomarkers for predicting dengue severity during the early stage.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  WHO classification; acute-phase proteins; biomarker detection; endothelial marker; hepatic marker; severe-dengue infection

Mesh:

Substances:

Year:  2022        PMID: 35560177      PMCID: PMC9113256          DOI: 10.1093/cei/uxac018

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.

Authors:  Martine Szyper Kravitz; Milena Pitashny; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

2.  Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells.

Authors:  Sheila Cabezas; Gustavo Bracho; Amanda L Aloia; Penelope J Adamson; Claudine S Bonder; Justine R Smith; David L Gordon; Jillian M Carr
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

3.  Antiviral activity of the long chain pentraxin PTX3 against influenza viruses.

Authors:  Patrick C Reading; Silvia Bozza; Brad Gilbertson; Michelle Tate; Silvia Moretti; Emma R Job; Erika C Crouch; Andrew G Brooks; Lorena E Brown; Barbara Bottazzi; Luigina Romani; Alberto Mantovani
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

4.  High Levels of Serum Angiopoietin 2 and Angiopoietin 2/1 Ratio at the Critical Stage of Dengue Hemorrhagic Fever in Patients and Association with Clinical and Biochemical Parameters.

Authors:  Maheshi Mapalagamage; Shiroma M Handunnetti; Ananda Rajitha Wickremasinghe; Gayani Premawansa; Sharmila Thillainathan; Tharanga Fernando; Karunayokiny Kanapathippillai; Aruna Dharshan De Silva; Sunil Premawansa
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

5.  The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.

Authors:  Yuanyuan Wang; Junli Hao; Xiaohong Liu; Hongxin Wang; Xin Zeng; Jing Yang; Lei Li; Xi Kuang; Tao Zhang
Journal:  Lipids Health Dis       Date:  2016-03-25       Impact factor: 3.876

6.  Patterns and causes of liver involvement in acute dengue infection.

Authors:  Samitha Fernando; Ananda Wijewickrama; Laksiri Gomes; Chameera T Punchihewa; S D P Madusanka; Harsha Dissanayake; Chandima Jeewandara; Hemantha Peiris; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  BMC Infect Dis       Date:  2016-07-08       Impact factor: 3.090

Review 7.  Acute phase protein response to viral infection and vaccination.

Authors:  Luis Perez
Journal:  Arch Biochem Biophys       Date:  2019-07-16       Impact factor: 4.013

Review 8.  The role of endothelial activation in dengue hemorrhagic fever and hantavirus pulmonary syndrome.

Authors:  Christina F Spiropoulou; Anon Srikiatkhachorn
Journal:  Virulence       Date:  2013-07-10       Impact factor: 5.882

9.  Dengue shock syndrome complicated with acute liver failure and kidney injury, infective endocarditis, and deep vein thrombosis: a case report.

Authors:  Keshinie Samarasekara; Janake Munasinghe
Journal:  J Med Case Rep       Date:  2018-10-30

Review 10.  Vascular endothelium: the battlefield of dengue viruses.

Authors:  Atanu Basu; Umesh C Chaturvedi
Journal:  FEMS Immunol Med Microbiol       Date:  2008-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.